Search

everythinglearnresearchcommunity

for

Search:↓

CCCA in women of African ancestry may be caused by PADI3 gene mutations and intense hair grooming.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Cantú syndrome is caused by mutations in the ABCC9 gene.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

ABCG2 protein marks stem-like skin cells in human epidermis.

A specific gene change in APCDD1 increases the risk of hair loss.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

MCHR2 gene duplications may be linked to alopecia areata.

Mutations in the PADI3 gene may cause central centrifugal cicatricial alopecia in women of African ancestry.

CCCA is a common, scarring hair loss in Black women that needs early detection.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.

A girl with Becker naevus syndrome has a genetic variant in the ACTB gene related to her symptoms.

CCCA causes progressive hair loss in Black women, starting from a central scalp patch.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

CCCA can affect both genders and all ages, and it has a genetic component.

A certain gene variation can affect protein production and is linked to male pattern baldness.

CCCA may be a fibroproliferative disorder, and anti-fibrotic therapies could help.

Most patients with Central Centrifugal Cicatricial Alopecia at the reviewed institution were middle-aged Black women, often with no symptoms, and commonly treated with topical medications.

Genetic changes in specific proteins contribute to hair loss in some women of African descent.

The document concludes that central centrifugal cicatricial alopecia (CCCA) should be considered in African American men with vertex hair loss and scalp symptoms, and that prompt diagnosis and treatment can slow disease progression.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

ACBP is essential for healthy skin and fur by maintaining the skin's barrier function.

Impaired ABCA5 activity disrupts cholesterol balance in hair follicle cells, affecting hair growth.

The document's content cannot be summarized because it is not accessible or understandable.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

Hair follicles are crucial for maintaining skin barrier function.